We are pleased that such a prestigious medical center has given clearance to proceed with this first study of our LEAPS-H1N1 treatment ... Given the nature and severity of the virus, we are working diligently with our CRO and Johns Hopkins, and actively preparing submissions to the FDA, to support the fastest and most effective way to conduct clinical trials going forward for this unique investigational treatment.